acute coronary syndrome. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Conditions
Interventions
Intervention 1: Intervention group: Theoretical and practical care intervention program along with an educational booklet (containing important points about the recognition of the disease and symptoms
Also, after completing the study, they will be provided with a training booklet for ethical issues, and the necessary explanations will be given to them in a meeting. Intervention 2: Control group: In
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Samples must be 18 years old or older With the approval of the doctor, they are allowed to carry out the care plan Do not have a disorder in the level of consciousness and have full awareness of the place, time and people Do not have visual or hearing impairments that interfere with the implementation of the care plan Have the first acute coronary syndrome People must be of Iranian nationality and have familiarity with the Persian language Have the desire and motivation to train and implement the care program for adaptation Be able to carry out care program interventions According to the medical record, apart from acute coronary syndrome, they should not have any other disorder in the heart system, such as heart failure, cardiomyopathy, congenital heart diseases, etc People should not have cognitive impairment or forgetfulness In the last 3 months, they have not suffered any unfortunate events such as the death of relatives The general and clinical condition of the patient should be stable as a result of the diagnostic and treatment measures performed At least 4 weeks have passed since their diagnosis According to the information in the file, use anti-anxiety or anti-depressant drugs
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life score in quality of life sf-36 questionnaire. Timepoint: Measuring the quality of life at the beginning of the study (before the start of the intervention), 1 month and 3 months after the end of the intervention. Method of measurement: Quality of life sf-36 questionnaire.;Cardiac anxiety score in standard cardiac anxiety questionnaire. Timepoint: Measurement of cardiac anxiety at the beginning of the study (before the start of the intervention), 1 month and 3 months after the end of the intervention. Method of measurement: cardiac anxiety questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMiaad Mirzapour
Esfahan University of Medical Sciences
Outcome results
None listed